Alzheimer's disease is a heavily researched area with clinical trials continuing and new therapeutic strategies and products to assess. The editors and contributors address contemporary topics in this area in a number of comprehensively referenced chapters, designed to stimulate discussion on where current treatment is heading. Contributors to this annual are all internationally renowned experts in their subspecialties based on clinical experience and scientific evidence for the treatment of this disease.